Dr. Emamekhoo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-265-1700Fax+1 608-263-9830
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2013 - 2016
TriHealth (Good Samaritan Hospital)Residency, Internal Medicine, 2010 - 2012
Shahid Beheshti University of Medical SciencesClass of 2003
Certifications & Licensure
CA State Medical License 2015 - 2025
WI State Medical License 2016 - 2025
OH State Medical License 2010 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- American Board of Preventive Medicine Clinical Informatics
Clinical Trials
- pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer Start of enrollment: 2018 Sep 10
Publications & Presentations
PubMed
- 4 citationsPathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy.Justine Panian, Ava Saidian, Kevin Hakimi, Archana Ajmera, William J Anderson
The Oncologist. 2024-10-03 - 3 citationsPerioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3...Mohamad E Allaf, Se-Eun Kim, Viraj Master, David F McDermott, Lauren C Harshman
The Lancet. Oncology. 2024-08-01 - 7 citationsPhase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer.Douglas G McNeel, Hamid Emamekhoo, Jens C Eickhoff, Christos E Kyriakopoulos, Ellen Wargowski
Journal for Immunotherapy of Cancer. 2023-12-14
Journal Articles
- Treatment Selection for Men with Metastatic Prostate Cancer Who Progress on Upfront Chemo‐Hormonal TherapyVadim Koshkin, Prateek Mendiratta, Brian I Rini, Pedro Barata, Christos Kyriakopoulos, Hamid Emamekhoo, Timothy Gilligan, The Prostate
Press Mentions
Combo Shows Promise in Advanced RCC with Brain MetastasesJune 5th, 2019
Carbone Experts Present Latest Research at World's Largest Cancer MeetingMay 31st, 2019
New Cancer Specialist Comes to MaustonApril 8th, 2017
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
